Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
5,986 | Dovepress* | 5,368+ | 1,265 | 6,633 | |
PubMed Central* | 618 | 148 | 766 | ||
Totals | 5,986 | 1,413 | 7,399 | ||
*Since 20 July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar